ORIGINAL RESEARCH
Published on 27 Jan 2025
Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
doi 10.3389/fimmu.2025.1492501
- 432 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Reducing Adverse Effects of Cancer Immunotherapy: Volume II
Community Series in Reducing Adverse Effects of Cancer Immunotherapy: Volume II
6,845
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 23 Jan 2025
Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
doi 10.3389/fimmu.2025.1534179
- 361 views
CASE REPORT
Published on 23 Dec 2024
Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature
doi 10.3389/fimmu.2024.1501415
- 523 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis
doi 10.3389/fimmu.2024.1495137
- 1,344 views
ORIGINAL RESEARCH
Published on 08 Oct 2024
Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database
doi 10.3389/fimmu.2024.1439231
- 1,283 views
CASE REPORT
Published on 30 Sep 2024
Case report: Fatal hemoptysis after effective treatment with tislelizumab and anlotinib in pulmonary sarcomatoid carcinoma
doi 10.3389/fonc.2024.1445358
- 741 views
CASE REPORT
Published on 16 Sep 2024
Sintilimab-induced myocarditis suspected in a patient with esophageal cancer and followed septic shock: case report and literature review
doi 10.3389/fonc.2024.1465395
- 873 views
- 2 citations
BRIEF RESEARCH REPORT
Published on 24 Jul 2024
Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy
doi 10.3389/fonc.2024.1396637
- 854 views
- 2 citations
CASE REPORT
Published on 05 Jul 2024
Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report
doi 10.3389/fimmu.2024.1423123
- 1,051 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 05 Jul 2024
Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy
doi 10.3389/fimmu.2024.1418286
- 856 views
ORIGINAL RESEARCH
Published on 19 Jun 2024
Baseline anemia and its associated factors among adult cancer patients at Northwest Amhara Regional State Referral Hospitals, Northwest Ethiopia, 2021
doi 10.3389/fonc.2024.1390052
- 624 views
CASE REPORT
Published on 10 Jun 2024
Secondary adrenocortical insufficiency after treatment with retifanlimab: a case report
doi 10.3389/fimmu.2024.1371527
- 690 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Inflammation
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: